ENTITY
SK Biopharmaceuticals

SK Biopharmaceuticals (326030 KS)

174
Analysis
Health Care • South Korea
SK Biopharmaceuticals Co., Ltd. researches and develops new drugs. The Company develops and markets brain disorders treatment drugs, central nervous system disorders treatment drugs, and other products. SK Biopharmaceuticals markets its products worldwide.
more
Company Presentation • 27 May 2026 14:00

Investor presentation

Company Presentation • 11 May 2023 14:00

Q1 2023

Company Presentation • 10 Aug 2023 14:00

Q2 2023

Company Presentation • 09 Nov 2023 15:00

Q3 2023

Company Presentation • 29 Jan 2024 15:00

Q4 2023

x